Integrating Preventive Cardiology into Routine Clinical Practice: Are We Doing Enough?
DOI:
https://doi.org/10.51253/pafmj.v76iSUPPL-4.14553Abstract
Cardiovascular disease is the most common cause of mortality in the world with almost 17.9 million deaths every year, most of which are preventable. Prevention cardiology includes lipidlowering treatment, hypertension management, diabetes management, smoking cessation, lifestyle change, and cardiac rehabilitation that are supported by strong evidence and endorsed by the American College of Cardiology/American Heart Association (ACC/AHA) and European Society of Cardiology (ESC) guidelines. 1,2 There is, however, an enduring, well-reported gap between what is recommended, and what patients get. Although numerous preventive frameworks are available, compliance is still suboptimal and the difference between evidencebased recommendations and real-life practice still cost lives. 3
South Asia bears a disproportionate share of this burden. South Asians experience coronary artery disease earlier frequently before age 50 with a more aggressive phenotype driven by insulin resistance, central obesity, elevated lipoprotein(a), and tobacco use. 4 In Pakistan, Tertiary cardiac centers receiving large numbers of patients with acute coronary syndrome (ACS) daily, proper preventive cardiology services are infrequent, cardiac rehabilitation enrolment is minimal, and post-discharge secondary prevention treatment is often discontinued after several months. The question this editorial poses is not rhetorical: are we doing enough? The answer, plainly is no.
Downloads
References
1. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American college of cardiology/American heart association task force on clinical practice guidelines: A report of the American college of cardiology/American heart association task force on clinical practice guidelines 2019; 140(11): e596–646.
http://doi.org/10.1161/CIR.0000000000000678
2. Laranjo L, Lanas F, Sun MC, Chen DA, Hynes L, Imran TF, et al. World heart federation roadmap for secondary prevention of cardiovascular disease: 2023 update. Glob Heart 2024; 19(1): 8.
http://doi.org/10.5334/gh.1278
3. Uchmanowicz I, Czapla M, Lomper K, Iovino P, Rosiek-Biegus M, Surma S, et al. Effective implementation of preventive cardiology guidelines: pathways to success. Eur J Prev Cardiol 2025;
http://doi.org/10.1093/eurjpc/zwaf448
4. Agarwala A, Satish P, Rifai MA, Mehta A, CainzosAchirica M, Shah NS, et al. Identification and management of atherosclerotic cardiovascular disease risk in south Asian populations in the U.s. JACC Adv 2023; 2(2): 100258.
http://doi.org/10.1016/j.jacadv.2023.100258
5. Llanes EJB, Thongtang N, Lee Z-V, Hoa T, Yee OH, Sukmawan R et al. Addressing adherence challenges in long-term statin treatment among Asian populations: Current gaps and proposed solutions. Am J Prev Cardiol 2025; 23(101019): 101019.
http://doi.org/10.1016/j.ajpc.2025.101019
6. Jones DW, Ferdinand KC, Taler SJ, Johnson HM, Shimbo D. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A report of the American college of cardiology/American heart association
joint committee on clinical practice guidelines 2025; 152(11): e114–218.
http://doi.org/10.1161/CIR.0000000000001356
7. Volterrani M, Caminiti G. Cardiac rehabilitation after acute coronary syndrome: still too far from the goal? Eur J Prev Cardiol 2024;
http://doi.org/10.1093/eurjpc/zwae220
8. Li J, Lai Y, Jiang C, Li M, Yang Z, Zhao M, et al. Fibroblast growth factor 23 and outcomes of atrial fibrillation: from clinical association to genetic evidence. Eur J Prev Cardiol 2025;
http://doi.org/10.1093/eurjpc/zwaf001
9. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/
AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: A report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol 2019; 73(24): e285–350.
http://doi.org/10.1016/j.jacc.2018.11.003
10. Jneid H, Chikwe J, Arnold SV, Bonow RO, Bradley SM, Chen EP, et al. 2024 ACC/AHA clinical performance and quality measures for adults with valvular and structural heart disease: A report of the American heart association/American college of cardiology
joint committee on performance measures. Circ Cardiovasc Qual Outcomes 2024; 17(4): e000129.
http://doi.org/10.1161/HCQ.0000000000000129
11. Chandra AA, Espiche C, Maliha M, Virani SS, Blumenthal RS, Rodriguez F, et al. American society for preventive cardiology 2024 cardiovascular disease prevention: Highlights and key sessions. Am J Prev Cardiol 2025; 21(100919): 100919.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.





